DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final tranche of 650,000 units (each a “Unit”) issued at a price of $0.28 per Unit, for gross proceeds of $182,000, of a non-brokered private placement initially announced on February 27, 2024 (“Private Placement”). Combined with the first closing announced on February 27, 2024, the aggregate number of Units is 2,064,286 and the aggregate gross proceeds amount to $578,000.08.
Related news for (DGNOF)
- DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
- DIAGNOS Announces the Engagement of Allele Capital Partners
- DIAGNOS Announces Amendment to Convertible Debentures
- DIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application
- DIAGNOS Provides Additional Information on Amendment to Convertible Debentures